Symic Adds Expertise to its Board MBC Biolabs2018-09-25T13:08:37-07:00February 23rd, 2015|Startup News|
Amarantus to Present Positive Alzheimer’s Disease Biomarker Data MBC Biolabs2018-09-25T13:09:16-07:00February 23rd, 2015|Startup News|
MedGenome to Raise $15M in Second Round of Funding MBC Biolabs2018-09-26T09:31:21-07:00February 19th, 2015|Startup News|
Amarantus Inks Alzheimer’s Biomarker Test Deal with Anavex MBC Biolabs2015-02-26T23:20:05-08:00February 18th, 2015|In the Media|
Senior Management Changes at Assembly Biosciences MBC Biolabs2018-09-25T13:11:57-07:00February 17th, 2015|Startup News|
John Mulcahy, SiteOne Therapeutics MBC Biolabs2018-09-25T13:13:33-07:00November 15th, 2014|Startup News|
Uri Lopatin, Assembly Biosciences MBC Biolabs2018-09-26T09:30:58-07:00November 13th, 2014|Startup News|
MedGenome keen to team-up with state govts MBC Biolabs2014-11-11T00:39:25-08:00November 11th, 2014|In the Media|
Innovation in fixed-dose combos: HIV/AIDS therapeutics edition MBC Biolabs2014-11-11T00:38:08-08:00November 11th, 2014|In the Media|
